FOXO4-DRI (12MG) FOR SALE

FOXO4-DRI (12mg) is a cutting-edge research peptide designed for advanced cellular senescence and apoptosis studies. This 12mg vial of high-purity peptide is intended for laboratory and experimental applications, offering researchers a reliable tool for exploring the mechanisms of aging, cell cycle regulation, and targeted cellular clearance. Its precision formulation ensures reproducible results, making FOXO4-DRI a preferred choice for scientific investigations in molecular biology and regenerative medicine research.

Product Overview

FOXO4-DRI is a synthetic peptide that has attracted significant attention in experimental research for its ability to selectively target senescent cells. By interacting with the FOXO4-p53 pathway, this peptide can induce apoptosis in aged or damaged cells while leaving healthy cells largely unaffected. Each vial contains 12mg of lyophilized peptide, produced to the highest laboratory standards to maintain purity, stability, and experimental reliability.

This peptide is particularly valuable for studies exploring aging mechanisms, senolytic therapies, and cellular rejuvenation. Researchers can leverage FOXO4-DRI to investigate the role of senescent cells in age-related diseases, tissue function, and cellular turnover.

Key Features and Benefits

• High-Purity Research Peptide: Ensures accurate experimental results

• 12mg Lyophilized Vial: Suitable for multiple laboratory protocols

• Targeted Senescent Cell Clearance: Enables focused studies on cell apoptosis

• Stable Lyophilized Format: Protects peptide integrity during storage

• Reproducible Experimental Outcomes: Consistent quality supports scientific reliability

Applications in Research

FOXO4-DRI (12mg) is widely utilized in studies of cellular aging, apoptosis, and regenerative biology. Its unique mechanism of action makes it suitable for:

• Senescence research and age-related cell studies

• Apoptosis and cell cycle regulation investigations

• Tissue regeneration and cellular rejuvenation experiments

• Testing novel senolytic therapeutic approaches

• Molecular biology studies focusing on the FOXO4-p53 pathway

Researchers value FOXO4-DRI for its targeted effect, which allows for more precise experimental results and clearer insights into the mechanisms of cellular aging and programmed cell death.

Quality and Manufacturing

Each batch of FOXO4-DRI is synthesized using advanced peptide production techniques and verified with high-performance liquid chromatography (HPLC) and mass spectrometry to ensure purity and consistency. The lyophilized format provides long-term stability when stored in proper conditions, including a cool, dry environment away from light and moisture.

Produced under rigorous laboratory standards, FOXO4-DRI guarantees reliability for research-focused applications, making it a high-quality addition to any peptide research inventory.

Why Choose FOXO4-DRI (12mg)

For laboratories investigating aging, cellular senescence, and targeted apoptosis, FOXO4-DRI (12mg) provides a precise, high-quality solution. Its selective mechanism and proven reproducibility make it a valuable tool for advancing research in cellular biology, regenerative medicine, and age-related studies.

By incorporating FOXO4-DRI into experimental protocols, scientists can study senescent cell pathways with confidence, benefiting from a peptide engineered for laboratory-grade reliability and performance.

Important Notice

FOXO4-DRI (12mg) is intended strictly for laboratory and research use. It is not approved for human consumption, medical use, or therapeutic applications. Proper handling by qualified professionals in controlled environments is essential to ensure safety and maintain peptide integrity.

---

Enhance your research capabilities with FOXO4-DRI (12mg) — a precision-engineered peptide designed for targeted cellular studies and advanced senescence research.